Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Gabapentin NDC 70518-2098 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Gabapentin 600mg 70518 2098 01

Gabapentin 600mg 70518 2098 01

Gabapentin is a prescription medication available in tablet form. The National Drug Code is 70518-2098-01, and the batch number and expiration date are not provided. The medication is manufactured by ACI Healthcare USA, Inc., Coral Springs, FL, and the quantity of medication included is 180 tablets. It must be kept out of reach of children. There are no specific instructions for dosage or usage; customers should refer to the package insert. It should be stored at room temperature between 63 and 77 degrees Fahrenheit (15-30 degrees Celsius), with allowable deviations up to 59-86 degrees Fahrenheit (15-30 degrees Celsius), as per the United States Pharmacopeia standards. This medication can only be obtained with a prescription from a licensed doctor.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Gabapentin is a medication available as 600 mg tablets in a bottle with 30 quantity. It is manufactured by ACI Healthcare USA, Inc. and its National Drug Code (NDC) is 70518-2098-00. The expiration date and lot number are not available. It should be kept out of children's reach and stored at room temperature. The package insert should be consulted for directions for use. This medicine requires a prescription and has been repackaged by RemedyRepack Inc.*

Figure 1 - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

Figure 1 - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

This is a formula to calculate the estimated creatinine clearance (CLOr) for patients based on their age, weight, and serum creatinine level. The formula is adjusted for female patients by multiplying the result by 0.85.*

Chem Structure - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

Chem Structure - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

figure01 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

figure01 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

figure02 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

figure02 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

figure03 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

figure03 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

The text describes a graph showing the proportion of patients who responded to treatment in controlled studies for PHN. Two studies are compared, with the percentage of responders shown for each. There are also three lines containing numbers, which appear to represent study groups and their associated costs.*

figure4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

figure4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.